Catalyst Wire Dossier Catalyst Wire Dossier

ivermectin 0.5% lotion

ivermectin · Actavis Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ivermectin 0.5% lotion, covering 2019-12-20 to 2020-09-17. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice [Phase 3]

See pricing